Sign in
4

Changes in Ownership

LEXICON PHARMACEUTICALS, INC. Filed Acc 0001127602-25-005209

Options or other derivatives

  • Chief Executive Officer acquired 3,774,480 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Exton Michael Chief Executive Officer 2025-02-13 Grant or award · Stock Option (Right to Buy) +2,264,690 2,264,690 D
Exton Michael Chief Executive Officer 2025-02-13 Grant or award · Restricted Stock Units +1,509,790 1,509,790 D
Loading xslF345X05/form4.xml…